No abstract available
Keywords:
Hodgkin's lymphoma; allogeneic transplantation; multi-relapsed; pegylated liposomal doxorubicin; response.
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Allografts
-
Antibiotics, Antineoplastic / administration & dosage
-
Antibiotics, Antineoplastic / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bendamustine Hydrochloride / administration & dosage
-
Brentuximab Vedotin
-
Carmustine / administration & dosage
-
Combined Modality Therapy
-
Cytarabine / administration & dosage
-
Doxorubicin / administration & dosage
-
Doxorubicin / analogs & derivatives*
-
Doxorubicin / therapeutic use
-
Drug Resistance, Neoplasm
-
Etoposide / administration & dosage
-
Hematopoietic Stem Cell Transplantation*
-
Hodgkin Disease / drug therapy*
-
Hodgkin Disease / radiotherapy
-
Hodgkin Disease / therapy
-
Humans
-
Immunoconjugates / administration & dosage
-
Immunoconjugates / adverse effects
-
Lenalidomide
-
Liposomes
-
Male
-
Melphalan / administration & dosage
-
Polyethylene Glycols / administration & dosage
-
Polyethylene Glycols / therapeutic use
-
Recurrence
-
Remission Induction
-
Salvage Therapy*
-
Thalidomide / administration & dosage
-
Thalidomide / analogs & derivatives
-
Transplantation, Autologous
-
Young Adult
Substances
-
Antibiotics, Antineoplastic
-
Immunoconjugates
-
Liposomes
-
liposomal doxorubicin
-
Cytarabine
-
Polyethylene Glycols
-
Thalidomide
-
Etoposide
-
Brentuximab Vedotin
-
Doxorubicin
-
Bendamustine Hydrochloride
-
Lenalidomide
-
Melphalan
-
Carmustine